Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

about

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.

P2860

Q40184483-74AC84C1-7A80-44B5-B26E-84B18D7E553C

P2860

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

Item

http://www.wikidata.org/entity/Q44399639

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en-gb

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@nl

type

Item

label

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en-gb

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@nl

prefLabel

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en-gb

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@nl

P1154

2-s2.0-84961201129

http://www.w3.org/2001/XMLSchema#string

P1433

CNS oncology

P1476

Future clinical potential of oncolytic virotherapy for pediatric CNS tumors.

@en

P2093

Julia V Cockle

http://www.w3.org/2001/XMLSchema#string

Susan V Picton

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of medulloblastoma with a modified measles virus

Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program

Herpes simplex virus oncolytic therapy for pediatric malignancies

A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.

Brainstem glioma: a review.

Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma

Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12

Atypical teratoid rhabdoid tumor: current therapy and future directions.

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy

P304

307-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/CNS.13.25

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alan Melcher

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25054575

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

6166538

http://www.w3.org/2001/XMLSchema#string

P953

87766/